Perner, A, Haase, N, Wetterslev, J, Aneman, A, Tenhunen, J, Guttormsen, A B, Klemenzson, G, Pott, F C, Bødker, K D, Bådstøløkken, P M, Bendtsen, A, Søe-Jensen, P, Tousi, H, Bestle, M H, Pawlowicz, M, Winding, R, Bülow, H-H, Kancir, C, Steensen, M, Nielsen, J T, Fogh, B, Madsen, K R, Larsen, N A G, Carlsson, M, Wiis, J, Petersen, J A, Iversen, S, Schøidt, O, Leivdal, S, Berezowicz, P, Pettilä, V, Ruokonen, E, Klepstad, P, Karlsson, S, Kaukonen, M, Rutanen, J, Karason, S, Kjældgaard, A L, Holst, L B, Wernerman, J & Scandinavian Critical Care Trials Group 2011, ' Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial ', Trials, vol. 12, no. 1, pp. 24 . https://doi.org/10.1186/1745-6215-12-24 Trials, Vol 12, Iss 1, p 24 (2011) Trials